Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2007-9-3
pubmed:abstractText
Left-ventricular hypertrophy (LVH) is a risk factor for cardiovascular morbidity. Antihypertensive treatment with angiotensin-converting enzyme inhibitors (ACEI) is able to induce the regression of LVH in adults. However, there has been no study of the ability of ACEI to induce the regression of LVH in children. Our aim was to investigate the effect of ramipril on left-ventricular mass and blood pressure (BP) in hypertensive children.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0895-7061
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
990-6
pubmed:dateRevised
2009-2-24
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
pubmed:affiliation
Department of Pediatrics, University Hospital Motol, Second School of Medicine, Charles University, Prague, Czech Republic. tomas.seeman@lfmotol.cuni.cz
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't